Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations
about
Malaria vaccine clinical trials: what's on the horizonCryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy.Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine.Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposureSafety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults.Progress with viral vectored malaria vaccines: A multi-stage approach involving "unnatural immunity".Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.Adenovirus-vectored Ebola vaccines.Recombinant modified vaccinia virus Ankara-based malaria vaccines.Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.Development of replication-deficient adenovirus malaria vaccines.Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop.DNA Vaccines: Recent Developments and the Future.Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial.Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effect.Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.CXCR3 T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria
P2860
Q28083110-FCB9A195-B839-4232-A854-4F38623159BEQ33551527-BC3CF7C3-EEA4-4819-A65C-3AA4F0E19E9EQ33577093-851DDF89-0D60-46D6-99F9-7BAEF24794E0Q33855899-378763AA-CD27-4F98-B008-8718DA59DE53Q34257253-4DEF09B2-96A6-4D93-8D07-089998FB8D2CQ36192765-AD1F97F0-85C1-49F2-AB08-D9870DD253ABQ36225504-1A65C9C8-0166-4311-A006-A22D0F70153DQ36393102-F1DC594C-7BAF-43E0-AB3B-A052A1A089CAQ36394177-E2DF246D-C658-4D52-854A-50066818C644Q37161928-627DFAFB-E5B4-4C73-9199-1284E3FF1B0FQ37229742-14E5A7A6-A4DF-49AA-9962-38E3A20757E7Q38569831-CD7AEBB1-139C-4E2F-85FA-B348E5290837Q38618898-C9009F38-1330-4BDC-B2EF-4A1CB677E1F3Q38762695-A1571383-7BEF-4A90-B8C3-BAC2B51B27CFQ38949194-202E9AD2-6546-4189-A34D-AFD4692816CAQ42753196-81016E45-D4B0-42A5-9880-BAF33DB06874Q45892465-7E7CF3B9-6D7B-47C5-B221-16EF509FBDA8Q46796163-1CD25637-0491-4CD7-83EC-1F9796A8283CQ47576664-51BCEB0C-8033-4385-9337-2246182899B0Q47993724-FC9D9F28-7F9D-49E0-870C-216B418C20DFQ50347547-80C344C5-38D2-431E-A206-3426EBC036F3Q56357275-E31B2F79-2491-4C35-98B9-AED9A21DE26E
P2860
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Translating the immunogenicity ...... to malaria-endemic populations
@ast
Translating the immunogenicity ...... to malaria-endemic populations
@en
Translating the immunogenicity ...... to malaria-endemic populations
@nl
type
label
Translating the immunogenicity ...... to malaria-endemic populations
@ast
Translating the immunogenicity ...... to malaria-endemic populations
@en
Translating the immunogenicity ...... to malaria-endemic populations
@nl
prefLabel
Translating the immunogenicity ...... to malaria-endemic populations
@ast
Translating the immunogenicity ...... to malaria-endemic populations
@en
Translating the immunogenicity ...... to malaria-endemic populations
@nl
P2093
P2860
P50
P356
P1433
P1476
Translating the immunogenicity ...... to malaria-endemic populations
@en
P2093
Abdoulie Drammeh
Alfredo Nicosia
Alison M Lawrie
Christopher J A Duncan
Domtila Kimani
Eleanor Berrie
Eva Kimani
Katie J Ewer
Katie L Flanagan
Miguel G Knight
P2860
P304
P356
10.1038/MT.2014.109
P50
P577
2014-06-16T00:00:00Z